SULF1 and prostate carcinoma: Consistent with this hypothesis, data gathered in the Prostate Cancer Transcriptome Atlas [62], comprising over 1300 clinical specimens from 38 cohorts, show a significant reduction of SULF1 expression in metastatic castrate-resistant PCa compared to benign and primary tumors (S11 Fig).